1.
Angélique Bobrie, et al., “Exosome secretion: molecular mechanisms and roles in
immune responses”, Traffic. 2011 Dec;12(12):1659-68.
2.
Michael G Harrington, et al., “The morphology and biochemistry of nanostructures
provide evidence for synthesis and signaling functions in human cerebrospinal fluid”,
Cerebrospinal Fluid Res. 2009 Sep 7;6:10.
3.
Jan Lötvall, et al., “Minimal experimental requirements for definition of extracellular
vesicles and their functions: a position statement from the International Society for
Extracellular Vesicles”, J Extracell Vesicles. 2014 Dec 22;3:26913.
4.
Joanna Kowal, et al., “Biogenesis and secretion of exosomes”, Curr Opin Cell Biol.
2014 Aug;29:116-25.
5.
Ariel Savina, et al., “The exosome pathway in K562 cells is regulated by Rab11”, J
Cell Sci. 2002 Jun 15;115(Pt 12):2505-15.
6.
Bin-Tao Pan, et al., “Fate of the transferrin receptor during maturation of sheep
reticulocytes in vitro: selective externalization of the receptor”, Cell. 1983
Jul;33(3):967-78.
7.
Rose M Johnstone, et al., “Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles (exosomes)”, J
95
Biol Chem. 1987 Jul 5;262(19):9412-20.
8.
Hadi Valadi, et al., “Exosome-mediated transfer of mRNAs and microRNAs is a
novel mechanism of genetic exchange between cells”, Nat Cell Biol. 2007
Jun;9(6):654-9.
9.
Lillian Kuo, et al., “ARRDC1 as a mediator of microvesicle budding”, Proc Natl
Acad Sci U S A. 2012 Mar 13;109(11):4025-6.
10. Graça Raposo, et al., “Extracellular vesicles: exosomes, microvesicles, and friends”,
J Cell Biol. 2013 Feb 18;200(4):373-83.
11. Clotilde Théry, et al., “Proteomic analysis of dendritic cell-derived exosomes: a
secreted subcellular compartment distinct from apoptotic vesicles”, J Immunol. 2001
Jun 15;166(12):7309-18.
12. Clotilde Théry, et al., “Minimal information for studies of extracellular vesicles 2018
(MISEV2018): a position statement of the International Society for Extracellular
Vesicles and update of the MISEV2014 guidelines”, J Extracell Vesicles. 2018 Nov
23;7(1):1535750.
13. Biomarkers Definitions Working Group., “Biomarkers and surrogate endpoints:
preferred definitions and conceptual framework”, Clin Pharmacol Ther. 2001
Mar;69(3):89-95.
96
14. Elena Castellanos-Rizaldos, et al., “Exosome-based detection of activating and
resistance EGFR mutations from plasma of non-small cell lung cancer patients”,
Oncotarget. 2019 Apr 23;10(30):2911-2920.
15. James McKiernan, et al., “A Novel Urine Exosome Gene Expression Assay to Predict
High-grade Prostate Cancer at Initial Biopsy”, JAMA Oncol. 2016 Jul 1;2(7):882-9.
16. Erik Margolis, et al., “Predicting high-grade prostate cancer at initial biopsy: clinical
performance of the ExoDx (EPI) Prostate Intelliscore test in three independent
prospective studies”, Prostate Cancer Prostatic Dis. 2022 Feb;25(2):296-301.
17. Berislav V Zlokovic, et al., “The blood-brain barrier in health and chronic
neurodegenerative disorders”, Neuron. 2008 Jan 24;57(2):178-201.
18. Davide Chiasserini, et al., “Proteomic analysis of cerebrospinal fluid extracellular
vesicles: a comprehensive dataset”, J Proteomics. 2014 Jun 25;106:191-204.
19. Hirohide Asai, et al., “Depletion of microglia and inhibition of exosome synthesis
halt tau propagation”, Nat Neurosci. 2015 Nov;18(11):1584-93.
20. Anne Stuendl, et al., “Induction of α-synuclein aggregate formation by CSF
exosomes from patients with Parkinson's disease and dementia with Lewy bodies”,
Brain. 2016 Feb;139(Pt 2):481-94.
21. Yohei Iguchi, et al., “Exosome secretion is a key pathway for clearance of
97
pathological TDP-43”, Brain. 2016 Dec;139(Pt 12):3187-3201.
22. Xuebing Ding, et al., “Exposure to ALS-FTD-CSF generates TDP-43 aggregates in
glioblastoma cells through exosomes and TNTs-like structure.”, Oncotarget. 2015
Sep 15;6(27):24178-91.
23. Saeed Sadigh-Eteghad, et al., “Amyloid-beta: a crucial factor in Alzheimer's disease”,
Med Princ Pract. 2015;24(1):1-10.
24. Alejandra del C. Alonso, et al., “Hyperphosphorylation induces self-assembly of tau
into tangles of paired helical filaments/straight filaments”, Proc Natl Acad Sci U S A.
2001 Jun 5;98(12):6923-8.
25. Maria Grazia Spillantini, et al., “Alpha-synuclein in Lewy bodies”, Nature. 1997 Aug
28;388(6645):839-40.
26. P. Nigel Leigh, et al., “Ubiquitin-immunoreactive intraneuronal inclusions in
amyotrophic lateral sclerosis. Morphology, distribution, and specificity”, Brain. 1991
Apr;114 ( Pt 2):775-88.
27. Tetsuaki Arai, et al., “TDP-43 is a component of ubiquitin-positive tau-negative
inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis”,
Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11.
28. Masato Hasegawa, et al., “Phosphorylated TDP-43 in frontotemporal lobar
98
degeneration and amyotrophic lateral sclerosis”, Ann Neurol. 2008 Jul;64(1):60-70.
29. Carolina Villarroya-Beltri, et al., “miRNAs into exosomes through binding to
specific motifs”, Nat Commun. 2013;4:2980.
30. Daniel Enderle, et al., “Characterization of RNA from Exosomes and Other
Extracellular Vesicles Isolated by a Novel Spin Column-Based Method”, PLoS One.
2015 Aug 28;10(8):e0136133.
31. Rup Tandan, et al., “Amyotrophic lateral sclerosis: Part 1. Clinical features,
pathology, and ethical issues in management”, Ann Neurol. 1985 Sep;18(3):271-80.
32. Vivek Majumder, et al., “TDP-43 as a potential biomarker for amyotrophic lateral
sclerosis: a systematic review and meta-analysis”, BMC Neurol. 2018 Jun
28;18(1):90.
33. Naoki Suzuki, et al., “Genetics of amyotrophic lateral sclerosis: seeking therapeutic
targets in the era of gene therapy”, J Hum Genet. 2022 Jun 13.
34. Yukio Kawahara, et al., “TDP-43 promotes microRNA biogenesis as a component of
the Drosha and Dicer complexes”, Proc Natl Acad Sci U S A. 2012 Feb
28;109(9):3347-52.
35. Axel Freischmidt, et al., “Systemic dysregulation of TDP-43 binding microRNAs in
amyotrophic lateral sclerosis”, Acta Neuropathol Commun. 2013 Jul 30;1:42.
99
36. Michele Benigni, et al., “Identification of miRNAs as Potential Biomarkers in
Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients”, Neuromolecular
Med. 2016 Dec;18(4):551-560.
37. Rachel Waller, et al., “Small RNA Sequencing of Sporadic Amyotrophic Lateral
Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to
Neural and Glial Activity”, Front Neurosci. 2018 Jan 9;11:731.
38. Mercedes Prudencio, et al., “Distinct brain transcriptome profiles in C9orf72associated and sporadic ALS”, Nat Neurosci. 2015 Aug;18(8):1175-82.
39. Kent Imaizumi, et al., “Pathogenic Mutation of TDP-43 Impairs RNA Processing in
a Cell Type-Specific Manner: Implications for the Pathogenesis of ALS/FTLD”,
eNeuro. 2022 Jun 8;9(3):ENEURO.0061-22.2022.
40. Kazutoshi Takahashi, et al., “Induction of pluripotent stem cells from adult human
fibroblasts by defined factors”, Cell. 2007 Nov 30;131(5):861-72.
41. Stuart M Chambers, et al., “Highly efficient neural conversion of human ES and iPS
cells by dual inhibition of SMAD signaling”, Nat Biotechnol. 2009 Mar;27(3):27580.
42. Jing Li, et al., “Identification and Characterization of 293T Cell-Derived Exosomes
by Profiling the Protein, mRNA and MicroRNA Components”, PLoS One. 2016 Sep
100
20;11(9):e0163043.
43. Ana Jovičić, et al., “Distinct repertoires of microRNAs present in mouse astrocytes
compared to astrocyte-secreted exosomes”, PLoS One. 2017 Feb 2;12(2):e0171418.
44. Zhong-Wei Du, et al., “Generation and expansion of highly pure motor neuron
progenitors from human pluripotent stem cells”, Nat Commun. 2015 Mar 25;6:6626.
45. Daisuke Shimojo, et al., “Rapid, efficient, and simple motor neuron differentiation
from human pluripotent stem cells”, Mol Brain. 2015 Dec 1;8(1):79.
46. Balendu Shekhar Jha, et al., “Motor neuron differentiation from pluripotent stem
cells and other intermediate proliferative precursors that can be discriminated by
lineage specific reporters”, Stem Cell Rev Rep. 2015 Feb;11(1):194-204.
47. Neeta Singh Roy, et al., “Enhancer-specified GFP-based FACS purification of human
spinal motor neurons from embryonic stem cells”, Exp Neurol. 2005
Dec;196(2):224-34.
48. Takahiro Nakano, et al., “Identification of a conserved 125 base-pair Hb9 enhancer
that specifies gene expression to spinal motor neurons”, Dev Biol. 2005 Jul
15;283(2):474-85.
49. Mark D Robinson, et al., “edgeR: a Bioconductor package for differential expression
analysis of digital gene expression data”, Bioinformatics. 2010 Jan 1;26(1):139-40.
101
50. R Core Team (2021). R: A language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria. URL https://www.Rproject.org/.
51. Revelle, W. (2022) psych: Procedures for Personality and Psychological Research,
Northwestern
University,
Evanston,
Illinois,
USA,
https://CRAN.R-
project.org/package=psych Version = 2.2.5.
52. Yoshimitsu Kanai, et al., “KIF5C, a novel neuronal kinesin enriched in motor
neurons”, J Neurosci. 2000 Sep 1;20(17):6374-84.
53. Brandi N Davis-Dusenbery, et al., “How to make spinal motor neurons”,
Development. 2014 Feb;141(3):491-501.
54. Darya D Yanshina, et al., “Structural features of the interaction of the 3'-untranslated
region of mRNA containing exosomal RNA-specific motifs with YB-1, a potential
mediator of mRNA sorting”, Biochimie. 2018 Jan;144:134-143.
55. Oswald Steward, et al., “Protein synthesis at synaptic sites on dendrites”, Annu Rev
Neurosci. 2001;24:299-325.
56. Fatih Arslan, et al., “Mesenchymal stem cell-derived exosomes increase ATP levels,
decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial
viability and prevent adverse remodeling after myocardial ischemia/reperfusion
102
injury”, Stem Cell Res. 2013 May;10(3):301-12.
57. Qinyu Ge, et al., “miRNA in plasma exosome is stable under different storage
conditions”, Molecules. 2014 Jan 27;19(2):1568-75.
58. Viswanathan Palanisamy, et al., “Nanostructural and transcriptomic analyses of
human saliva derived exosomes”, PLoS One. 2010 Jan 5;5(1):e8577.
59. Nobuyoshi Kosaka, et al., “Circulating microRNA in body fluid: a new potential
biomarker for cancer diagnosis and prognosis”, Cancer Sci. 2010 Oct;101(10):208792.
60. Hiroshi Mitsumoto, et al., “Clinical trials in amyotrophic lateral sclerosis: why so
many negative trials and how can trials be improved?”, Lancet Neurol. 2014
Nov;13(11):1127-1138.
61. Michael Benatar, et al., “ALS biomarkers for therapy development: State of the field
and future directions”, Muscle Nerve. 2016 Feb;53(2):169-82.
62. Thierry S Reijn, et al., “CSF neurofilament protein analysis in the differential
diagnosis of ALS”, J Neurol. 2009 Apr;256(4):615-9.
63. Koen Poesen, et al., “Neurofilament markers for ALS correlate with extent of upper
and lower motor neuron disease”, Neurology. 2017 Jun 13;88(24):2302-2309.
64. Osamu Kano, et al., “Neuronal apoptosis inhibitory protein is implicated in
103
amyotrophic lateral sclerosis symptoms”, Sci Rep. 2018 Jan 8;8(1):6.
65. David P Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function”, Cell.
2004 Jan 23;116(2):281-97.
66. Hanbo Chen (2022), VennDiagram: Generate High-Resolution Venn and Euler Plots.
R package version 1.7.3., https://CRAN.R-project.org/package=VennDiagram
67. Simone Picelli, et al., “Smart-seq2 for sensitive full-length transcriptome profiling in
single cells”, Nat Methods. 2013 Nov;10(11):1096-8.
68. Christine M Clemson, et al., “An architectural role for a nuclear noncoding RNA:
NEAT1 RNA is essential for the structure of paraspeckles”, Mol Cell. 2009 Mar
27;33(6):717-26.
69. Ping Ji, et al., “MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer”, Oncogene. 2003
Sep 11;22(39):8031-41.
70. Pei-Jing Zhang, et al., “CUE domain containing 2 regulates degradation of
progesterone receptor by ubiquitin-proteasome”, EMBO J. 2007 Apr 4;26(7):183142.
71. Wei-Na Zhang, et al., “CUEDC2 (CUE domain-containing 2) and SOCS3
(suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase
104
1/signal transducers and activators of transcription 3 signaling”, J Biol Chem. 2012
Jan 2;287(1):382-392.
72. Davina J Hensman Moss, et al., “C9orf72 expansions are the most common genetic
cause of Huntington disease phenocopies”, Neurology. 2014 Jan 28;82(4):292-9.
73. Yohsuke Yagi, et al., “Next-generation sequencing-based small RNA profiling of
cerebrospinal fluid exosomes”, Neurosci Lett. 2017 Jan 1;636:48-57.
74. Gaelle Lachenal, et al., “Release of exosomes from differentiated neurons and its
regulation by synaptic glutamatergic activity”, Mol Cell Neurosci. 2011
Feb;46(2):409-18.
75. Tsuyoshi Sekizawa, et al., “Cerebrospinal fluid interleukin 6 in amyotrophic lateral
sclerosis: immunological parameter and comparison with inflammatory and noninflammatory central nervous system diseases”, J Neurol Sci. 1998 Feb
5;154(2):194-9.
76. Jee-Eun Kim, et al., “Altered nucleocytoplasmic proteome and transcriptome
distributions in an in vitro model of amyotrophic lateral sclerosis”, PLoS One. 2017
Apr 28;12(4):e0176462.
77. Dohoon Kim, et al., “SIRT1 deacetylase protects against neurodegeneration in
models for Alzheimer's disease and amyotrophic lateral sclerosis”, EMBO J. 2007
105
Jul 11;26(13):3169-79.
78. Ekene Anakor, et al., “The Neurotoxicity of Vesicles Secreted by ALS Patient
Myotubes Is Specific to Exosome-Like and Not Larger Subtypes”, Cells. 2022 Mar
1;11(5):845.
79. Zhifen Yang, et al., “USP18 negatively regulates NF-κB signaling by targeting TAK1
and NEMO for deubiquitination through distinct mechanisms”, Sci Rep. 2015 Aug
4;5:12738.
80. Nadine Honke, et al., “Multiple functions of USP18”, Cell Death Dis. 2016 Nov
3;7(11):e2444.
81. Ji An Kang, et al., “Emerging Roles of USP18: From Biology to Pathophysiology”,
Int J Mol Sci. 2020 Sep 17;21(18):6825.
82. Srikanth Karnati, et al., “Mammalian SOD2 is exclusively located in mitochondria
and not present in peroxisomes”, Histochem Cell Biol. 2013 Aug;140(2):105-17.
83. James M Flynn, et al., “SOD2 in mitochondrial dysfunction and neurodegeneration”,
Free Radic Biol Med. 2013 Sep;62:4-12.
84. Katherine J Wert, et al., “Extracellular superoxide dismutase (SOD3) regulates
oxidative stress at the vitreoretinal interface”, Free Radic Biol Med. 2018 Aug
20;124:408-419.
106
...
論文の公開元へ
